Complete Filing Data
ONCOLYTICS BIOTECH INC reported Equity of -$3.80 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ONCOLYTICS BIOTECH INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$28.8M | -$22.8M | -$27.8M | -$24.8M | -$26.3M | -$22.5M | -$33.1M | -$17.0M | -$15.6M | -$15.1M | -$13.7M |
| Research And Development Expense | $13.3M | $15.4M | $17.7M | $15.4M | $12.9M | $12.9M | $10.8M | $10.0M | $9.4M | $9.8M | $8.6M |
| Profit Loss From Operating Activities | -$35.0M | -$33.8M | -$26.9M | -$26.2M | -$25.5M | -$20.4M | -$17.3M | -$15.6M | -$15.3M | -$13.9M | |
| Profit Loss Before Tax | -$31.6M | -$27.7M | -$24.8M | -$26.3M | -$22.5M | -$33.1M | -$16.5M | -$15.5M | -$15.1M | -$13.7M | |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $417.0K | -$118.0K | $274.0K | -$12.0K | -$64.0K | -$143.4K | $233.8K | -$180.3K | -$206.9K | $480.9K | |
| Income Tax Expense Continuing Operations | $130.0K | $97.0K | $84.0K | $49.0K | $0.00 | $0.00 | $548.0K | $141.5K | $9.4K | $3.2K | |
| Comprehensive Income | -$31.3M | -$27.9M | -$24.6M | -$26.3M | -$22.6M | -$33.3M | -$16.8M | -$15.8M | -$15.3M | -$13.2M | |
| Interest Revenue Expense | -$139.0K | -$71.0K | $76.0K | -$92.0K | -$69.0K | ||||||
| Interest Expense On Lease Liabilities | $91.7K | $68.5K | $94.8K | $0.00 | $0.00 | ||||||
| General And Administrative Expense | $15.4M | $10.1M | $16.1M | $11.5M | $13.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity | -$3.8M | $3.3M | $19.6M | |||||||||
| Cash And Cash Equivalents | $15.9M | $34.9M | $11.7M | $41.3M | $31.2M | $14.1M | $13.7M | $11.8M | $12.0M | $24.0M | $14.2M | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $239.0K | $8.0K | $55.0K | $286.0K | $29.0K | $10.9K | $107.5K | $105.8K | $23.5K | $108.3K | ||
| Interest Income On Cash And Cash Equivalents | $1.2M | $1.3M | $528.0K | $99.0K | $121.0K | $179.3K | $173.5K | $130.1K | $163.9K | $197.9K | ||
| Cash Flows From Used In Operations | -$27.0M | -$28.4M | -$23.4M | -$22.4M | -$22.1M | -$19.9M | -$11.9M | -$14.9M | -$12.5M | -$15.0M | ||
| Cash Flows From Used In Investing Activities | -$239.0K | $20.2M | -$20.4M | -$286.0K | -$29.0K | -$10.9K | -$107.5K | $2.0M | -$51.4K | -$137.6K | ||
| Cash Flows From Used In Financing Activities | $6.6M | $32.0M | $12.2M | $33.0M | $39.8M | $21.0M | $13.3M | $12.8M | $956.1K | $23.7M | ||
| Rightofuse Assets | $901.0K | $365.0K | $296.0K | $584.0K | $372.0K | $430.7K | $808.0K | |||||
| Noncurrent Contract Liabilities | $6.7M | $6.7M | $6.7M | $6.7M | $6.7M | $6.7M | $5.8M | $4.6M | $0.00 | |||
| Liabilities | $11.4M | $10.1M | $11.3M | $10.8M | $9.8M | $9.6M | $19.8M | $8.7M | $9.9M | $4.1M | ||
| Assets | $7.6M | $13.4M | $38.8M | $37.3M | $45.9M | $34.3M | $19.7M | $14.9M | $18.2M | $14.8M | ||
| Increase Decrease Through Incentive Share Awards Equity | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Trade And Other Current Payables | $4.8M | $3.6M | $3.7M | $2.0M | $1.8M | $3.2M | $1.8M | $3.7M | $4.1M | |||
| Retained Earnings | -$477.7M | -$446.0M | -$418.3M | -$393.4M | -$367.1M | -$344.6M | -$311.5M | -$294.4M | -$278.8M | |||
| Property Plant And Equipment | $411.0K | $282.0K | $356.0K | $392.0K | $236.7K | $296.8K | $412.7K | $333.4K | $320.0K | |||
| Other Current Receivables | $68.0K | $15.0K | $521.0K | $866.0K | $89.7K | $2.1M | $51.7K | $37.7K | $54.4K | |||
| Equity And Liabilities | $20.2M | $38.8M | $37.3M | $45.9M | $34.3M | $19.7M | $14.9M | $18.2M | $14.8M | |||
| Current Liabilities | $6.7M | $4.2M | $3.9M | $2.7M | $2.7M | $12.9M | $2.8M | $5.2M | $4.1M | |||
| Current Assets | $18.9M | $38.2M | $35.7M | $44.9M | $33.7M | $18.9M | $14.5M | $17.8M | $14.4M | |||
| Cash Outflow For Leases | $348.0K | $407.0K | $381.0K | $366.0K | $461.0K | $447.5K | $0.00 | |||||
| Accumulated Other Comprehensive Income | $961.0K | $544.0K | $662.0K | $388.0K | $400.2K | $464.1K | $607.5K | $373.7K | $554.1K | |||
| Other Current Liabilities | $1.6M | $332.0K | $0.00 | $352.0K | $124.0K | $847.2K | $61.3K | $0.00 | ||||
| Increase Decrease Through Exercise Of Warrants Equity | $71.0K | $687.0K | $6.3M | $9.2M | -$330.00 | |||||||
| Current Derivative Financial Liabilities | $0.00 | $200.0K | $79.0K | $56.0K | $531.2K | $8.5M | $0.00 | |||||
| Adjustments For Depreciation Right Of Use Assets | $304.0K | $322.0K | $299.0K | $322.0K | $357.0K | $362.6K | ||||||
| Noncurrent Lease Liabilities | $787.0K | $290.0K | $157.0K | $361.0K | $153.2K | $166.4K | ||||||
| Current Lease Liabilities | $277.0K | $133.0K | $216.0K | $294.0K | $248.9K | $339.8K | ||||||
| Cash Flows From Used In Decrease Increase In Shortterm Deposits And Investments | $0.00 | $0.00 | $2.1M | -$27.8K | -$29.3K | |||||||
| Adjustmentsfor Lease Amortization | $0.00 | $0.00 | $8.2K | $0.00 | $0.00 | |||||||
| Noncurrent Liabilities | $6.9M | $6.9M | $5.9M | $4.6M | $0.00 | |||||||
| Noncurrent Assets | $609.1K | $727.5K | $412.7K | $333.4K | $320.0K | |||||||
| Current Contract Liabilities | $0.00 | $927.4K | $1.5M | $0.00 | ||||||||
| Expense From Equitysettled Sharebased Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets | $0.00 | $151.0K | $0.00 | $0.00 | ||||||||
| Issue Of Equity | $17.7M | $13.3M | $34.2M | |||||||||
| Current Receivables From Contracts With Customers | $0.00 | $4.8M | $0.00 | |||||||||
| Other Noncurrent Liabilities | $0.00 | $52.4K | $0.00 | |||||||||
| Depreciation Rightofuse Assets | $357.2K | $362.6K | $0.00 | |||||||||
| Current Financial Assets Availableforsale | $0.00 | $20.5M | $0.00 | |||||||||
| Stockholders Equity | -$3.8M | $3.3M | $19.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Exercise Of Options | $0.00 | $781.0K | $12.0K | $238.0K | $241.0K | $0.00 | $123.5K | $343.4K | $0.00 | $0.00 | |
| Increase Decrease In Working Capital | -$3.5M | -$1.8M | -$391.0K | $908.0K | -$210.0K | $1.8M | -$3.9M | -$180.9K | -$2.2M | $1.1M | |
| Increase Decrease In Cash And Cash Equivalents | -$20.6M | $23.8M | -$31.6M | $10.3M | $17.7M | $1.1M | $1.3M | -$95.6K | -$11.6M | $8.5M | |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $1.6M | -$522.0K | $2.0M | -$254.0K | -$604.0K | -$650.4K | $592.3K | -$102.6K | -$409.2K | $1.4M | |
| Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities | $0.00 | $20.2M | $0.00 | $0.00 | |||||||
| Proceeds From Exercise Of Warrants | $65.0K | $0.00 | $0.00 | $231.0K | |||||||
| Proceeds From Issue Of Ordinary Shares | 0.00 | 0.00 | 4.3M | ||||||||
| Net Cash Provided By Used In Operating Activities | -$20.1M | -$19.9M | |||||||||
| Net Cash Provided By Used In Investing Activities | -$6.0K | -$174.0K | |||||||||
| Net Cash Provided By Used In Financing Activities | $14.1M | $5.0M | |||||||||
| Share Based Compensation | $3.1M | $2.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Shares | 76.5M | 67.6M | 58.0M | 53.5M | 40.3M | 22.1M | 16.0M | 13.9M | 12.6M | 112.6M | |
| Adjusted Weighted Average Shares | 76.5M | 67.6M | 58.0M | 53.5M | 40.3M | 22.1M | 16.0M | 13.9M | 12.6M | 112.6M | |
| Diluted Earnings Loss Per Share | $-0.41 | $-0.41 | $-0.43 | $-0.49 | $-0.56 | $-1.50 | |||||
| Basic Earnings Loss Per Share | $-0.41 | $-0.41 | $-0.43 | $-0.49 | $-0.56 | $-1.50 | |||||
| Basic And Diluted Earnings Loss Per Share | $-0.56 | $-1.50 | $-1.06 | $-1.12 | $-1.20 | $-0.12 | |||||
| Number Of Shares Issued | 55.0M | 46.2M | 32.2M | 17.4M | 14.9M | 121.3M | |||||
| Earnings Per Share Diluted | $-0.30 | $-0.30 | |||||||||
| Earnings Per Share Basic | $-0.30 | $-0.30 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share Issue Related Cost | $751.0K | $2.8M | $764.0K | $1.3M | $1.7M | $854.3K | $2.4M | $1.4M | $500.2K | $753.7K |
| Increase Decrease Through Sharebased Payment Transactions | $2.7M | $1.9M | $2.4M | $3.8M | $2.6M | $1.5M | $1.4M | $578.7K | $406.1K | $429.5K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$838.0K | $282.0K | -$1.6M | $426.0K | $645.0K | $353.2K | -$374.3K | -$124.8K | -$139.8K | -$816.3K |
| Adjustments For Sharebased Payments | $2.7M | $1.9M | $2.4M | $3.8M | $2.6M | $1.5M | $1.4M | $578.7K | $406.1K | $429.5K |
| Adjustments For Depreciation And Amortisation Expense | $120.0K | $81.0K | $93.0K | $130.0K | $89.0K | $123.0K | $95.4K | $90.8K | $162.2K | $180.4K |
| Operating Expense | $11.5M | $13.3M | $12.5M | $9.6M | $7.2M | $6.2M | $5.5M | $5.3M | ||
| Gains Losses On Change In Fair Value Of Derivatives | $1.2M | $5.3M | -$20.0K | $17.0K | $3.5M | -$12.6M | $0.00 | $0.00 | ||
| Issued Capital | $438.2M | $430.9M | $404.0M | $391.3M | $356.8M | $311.1M | $285.2M | $271.7M | $262.3M | |
| Increase Decrease Through Exercise Of Options | $781.0K | $12.0K | $238.0K | $241.0K | $123.5K | $343.4K | ||||
| Additional Paidin Capital | $44.5M | $42.1M | $40.1M | $34.2M | $31.0M | $29.3M | $28.3M | $27.0M | $26.6M | |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $961.0K | -$475.0K | $1.7M | -$136.0K | -$659.0K | -$316.7K | $610.1K | |||
| Warrantsand Rights Outstanding | $0.00 | $3.6M | $3.6M | $3.6M | $3.6M | $3.6M | $0.00 | |||
| Current Prepaid Expenses | $2.8M | $2.4M | $2.7M | $701.0K | $1.2M | $260.8K | ||||
| Purchase Of Financial Instruments Classified As Investing Activities | $0.00 | $0.00 | $20.3M | $0.00 | $0.00 | |||||
| Adjustments For Provisions | $0.00 | $0.00 | $67.6K | $0.00 | $0.00 | |||||
| Current Prepayments | $1.9M | $3.2M | $3.0M | $2.8M | ||||||
| Adjustments For Gains Losses On Change In Fair Value Of Derivatives | $1.2M | $5.3M | -$20.0K | $17.0K | ||||||
| Noncurrent Prepayments | $0.00 | $998.0K | $0.00 |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.